[1]王学琦,李丰华,张荣华,等.温肾汤治疗早期糖尿病肾病80例[J].西部中医药,2013,26(09):62-63.
 WANG Xueqi,LI Fenghua,ZHANG Ronghua,et al.WenShenTang for 80 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):62-63.
点击复制

温肾汤治疗早期糖尿病肾病80例
分享到:

《西部中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
26
期数:
2013年09期
页码:
62-63
栏目:
报道·临证经验
出版日期:
2013-09-15

文章信息/Info

Title:
WenShenTang for 80 Cases of Early Diabetic Nephropathy
文章编号:
1004-6852(2013)09-0062-02
作者:
王学琦李丰华张荣华俞登虎
古浪县人民医院内科,甘肃 古浪 733100
Author(s):
WANG Xueqi LI Fenghua ZHANG Ronghua YU Denghu
Department of Internal Medicine of Gulang County People′s Hospital, Gulang 733100, China
关键词:
糖尿病肾病温肾汤尿蛋白血脂
Keywords:
diabetic nephropathy WenShenTang proteinuria blood lipid
分类号:
R587.2
文献标志码:
B
摘要:
目的:观察温肾汤治疗早期糖尿病肾病(DN)的临床疗效。方法:80例早期DN患者在采用糖尿病教育、调节控制饮食、适当运动、药物控制血糖的基础上给予温肾汤,1剂/d,水煎分2次口服。4周为1疗程,连续治疗2个疗程后观察患者尿微量蛋白/肌酐(MA/Cr)、血β2微球蛋白(β2-MG)、尿β2-MG、尿α1微球蛋白(α1-MG)、血肌酐(SCr)、血浆纤维蛋白(FIB)、血脂[总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)]变化情况。结果:治疗后MA/Cr、血β2-MG、尿β2-MG、尿α1-MG、血SCr、血FIB均有减少(P<0.05),TC、TG、LDL-C、HDL-C明显改善(P<0.05)。结论:温肾汤能有效延缓早期DN的进展,减少尿蛋白,显著改善血脂。
Abstract:
Objective: To observe clinical effects of WenShenTang in treating early diabetic nephropathy (DN). Method: All 80 patients took WenShenTang on the foundation of diabetes education, diet regulation, proper exercise and blood glucose controlling through drugs, one dose per day, water decocted and taking twice. Four weeks were one course of treatment, and the changes of microalbuminuria/creatinine(MA/Cr), blood β2 microglobulin (β2-MG), urinary β2 microglobulin (β2-MG), urinary α1 microglobulin (α1-MG), serum creatinine(SCr), plasma fibrinogen (FIB), total cholesterol (TC), glycerin trilaurate (TG), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol(LDL-C) were observed after two consecutive courses of treatment. Result: After treating, MA/Cr, blood β2-MG, urinary β2-MG, urinary α1-MG, SCr and FIB were decreased (P<0.05), TC, TG, LDL-C and HDL-C were improved obviously(P<0.05). Conclusion: WenShenTang could effectively delay the development of early DN, reduce proteinuria and remarkably improve blood lipid.

相似文献/References:

[1]朱苗蕊,指导:金智生.糖脂平治疗早期糖尿病肾病60例疗效观察*[J].西部中医药,2013,26(03):74.
 ZHU Miaorui,Director: JIN Zhisheng.Clinical Observation on TangZhiPing in Treating 60 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):74.
[2]连琯,史晓伟.当归补血汤合金水宝治疗早期糖尿病肾病16例临床观察[J].西部中医药,2013,26(06):68.
 LIAN Guan,SHI Xiaowei.Clinical Observation on DangGui BuXueTang and JinShuiBao in Treating 16 Cases of Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):68.
[3]林晓芬,黄燕璇.益肾汤联合厄贝沙坦及胰激肽原酶治疗早期糖尿病肾病的疗效观察[J].西部中医药,2013,26(07):68.
 LIN Xiaofen,HUANG Yanxuan.Clinical Observation on YiShenTang Combined with Irbesartan and Pancreatic Kininogenase in the Treatment for Early Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):68.
[4]马天寿.血塞通联合西药治疗糖尿病肾病80例[J].西部中医药,2013,26(08):96.
 MA Tianshou.XueSaiTong Injection and Western Medicine in Treating 80 Cases of Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):96.
[5]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病随机对照试验报告质量评价[J].西部中医药,2013,26(12):1.
 REN Fang,XU Houqian.Quality Evaluation of the Report for Randomized Controlled Trials of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2013,26(09):1.
[6]杨华,曾娟花.血清TNF与2型糖尿病肾病及其中医证型关系的临床研究[J].西部中医药,2014,27(01):11.
 YANG Hua,ZENG Juanhua.Clinical Study on the Relationship between Serum TNF and Type 2 Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(09):11.
[7]任芳,徐厚谦△.黄芪注射液治疗糖尿病肾病有效性及安全性的系统评价[J].西部中医药,2014,27(01):77.
 REN Fang,XU Houqian.Systematic Review of the Effectiveness and Safety of HuangQi Injection in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(09):77.
[8]丁夏楠,许筠△,苏建平,等.益肾逐瘀方治疗糖尿病肾病蛋白尿37例[J].西部中医药,2014,27(04):96.
 DING Xianan,XU Jun,SU Jianping,et al.Treatment for Proteinuria of 37 Patients with Diabetic Nephropathy by Kidney-invigorating Stagnation-dispelling Prescription[J].Western Journal of Traditional Chinese Medicine,2014,27(09):96.
[9]孙慧,李彩萍.雷公藤多苷联合二甲双胍治疗糖尿病肾病临床观察[J].西部中医药,2014,27(07):82.
 SUN Hui,LI Caiping.Clinical Observation on Tripterygium Glycosides and Metformin in Treating Diabetic Nephropathy[J].Western Journal of Traditional Chinese Medicine,2014,27(09):82.
[10]肖远莉.循证护理的优效性及影响因素分析———来自终末期糖尿病肾病患者血液透析的证据[J].西部中医药,2014,27(08):127.

备注/Memo

备注/Memo:
收稿日期:2013-05-28 作者简介:王学琦(1963—),男,副主任医师。研究方向:心血管疾病的中西医诊治。
更新日期/Last Update: 2013-09-15